Affiliation:
1. Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
2. College of Public Health, University of Georgia, Athens, GA 30602, USA
Abstract
Purpose: To systematically review published cost-effectiveness analyses of Evidence-Based Interventions (EBIs) recommended by the United States Community Preventive Services Task Force (CPSTF) to increase breast and cervical cancer screening. Methods: We searched PubMed and Embase for prospective cost-effectiveness evaluations of EBIs for breast and cervical cancer screening since 1999. We reviewed studies according to the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) and compared the incremental cost-effectiveness ratio (ICERs), defined as cost per additional woman screened, adjusted to 2021 USD, within and across EBIs by cancer type. Results: We identified eleven studies meeting our review criteria: nine were breast cancer-focused, one breast and cervical cancer combined, and one cervical only, which together reported twenty-four cost-effectiveness assessments of outreach programs spanning eight EBIs. One-on-one education programs were the most common EBI evaluated. The average ICER across breast cancer studies was USD 545 (standard deviation [SD] = USD 729.3), while that for cervical cancer studies was USD 197 (SD = 186.6. Provider reminder/recall systems for women already linked to formal care were the most cost-effective, with an average ICERs of USD 41.3 and USD 10.6 for breast and cervical cancer, respectively. Conclusions: Variability in ICERs across and within EBIs reflect the population studied, the specific EBI, and study settings, and was relatively high. ICER estimate uncertainty and the potential for program replicability in other settings and with other populations were not addressed. Given these limitations, using existing cost-effectiveness estimates to inform program funding allocations is not warranted at this time. Additional research is needed on outreach programs for cervical cancer and those which serve minority populations for either of the female cancer screens.
Funder
Centers for Disease Control and Prevention
Reference42 articles.
1. American Cancer Society (2021, September 23). Key Statistics for Cervical Cancer. Available online: https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html.
2. American Cancer Society (2021, September 23). How Common Is Breast Cancer? About Breast Cancer 2021. Available online: https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html.
3. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society;Fontham;CA A Cancer J. Clin.,2020
4. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society;Oeffinger;JAMA,2015
5. (2023, October 01). Healthy People 2030, Increase the Proportion of Females Who Get Screened for Breast Cancer—C-05. Objectives, Available online: https://health.gov/healthypeople/objectives-and-data/browse-objectives/cancer/increase-proportion-females-who-get-screened-breast-cancer-c-05.